Pediatric Neuroblastoma Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pediatric Neuroblastoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatric Neuroblastoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatric Neuroblastoma Treatment Overall Market Size
2.1 Global Pediatric Neuroblastoma Treatment Market Size: 2022 VS 2029
2.2 Global Pediatric Neuroblastoma Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pediatric Neuroblastoma Treatment Players in Global Market
3.2 Top Global Pediatric Neuroblastoma Treatment Companies Ranked by Revenue
3.3 Global Pediatric Neuroblastoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pediatric Neuroblastoma Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pediatric Neuroblastoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric Neuroblastoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Pediatric Neuroblastoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Pediatric Neuroblastoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pediatric Neuroblastoma Treatment Market Size Markets, 2022 & 2029
4.1.2 Immunotherapy
4.1.3 Chemotherapy
4.1.4 Others
4.2 By Type - Global Pediatric Neuroblastoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Pediatric Neuroblastoma Treatment Revenue, 2018-2023
4.2.2 By Type - Global Pediatric Neuroblastoma Treatment Revenue, 2024-2029
4.2.3 By Type - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pediatric Neuroblastoma Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Pediatric Neuroblastoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Pediatric Neuroblastoma Treatment Revenue, 2018-2023
5.2.2 By Application - Global Pediatric Neuroblastoma Treatment Revenue, 2024-2029
5.2.3 By Application - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pediatric Neuroblastoma Treatment Market Size, 2022 & 2029
6.2 By Region - Global Pediatric Neuroblastoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Pediatric Neuroblastoma Treatment Revenue, 2018-2023
6.2.2 By Region - Global Pediatric Neuroblastoma Treatment Revenue, 2024-2029
6.2.3 By Region - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pediatric Neuroblastoma Treatment Revenue, 2018-2029
6.3.2 US Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.3.3 Canada Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.3.4 Mexico Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pediatric Neuroblastoma Treatment Revenue, 2018-2029
6.4.2 Germany Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4.3 France Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4.4 U.K. Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4.5 Italy Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4.6 Russia Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.4.8 Benelux Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pediatric Neuroblastoma Treatment Revenue, 2018-2029
6.5.2 China Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.5.3 Japan Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.5.4 South Korea Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.5.6 India Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pediatric Neuroblastoma Treatment Revenue, 2018-2029
6.6.2 Brazil Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.6.3 Argentina Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue, 2018-2029
6.7.2 Turkey Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.7.3 Israel Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Pediatric Neuroblastoma Treatment Market Size, 2018-2029
6.7.5 UAE Pediatric Neuroblastoma Treatment Market Size, 2018-2029
7 Pediatric Neuroblastoma Treatment Companies Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Company Summary
7.1.2 United Therapeutics Business Overview
7.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Major Product Offerings
7.1.4 United Therapeutics Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.1.5 United Therapeutics Key News & Latest Developments
7.2 Apeiron Biologics
7.2.1 Apeiron Biologics Company Summary
7.2.2 Apeiron Biologics Business Overview
7.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Major Product Offerings
7.2.4 Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.2.5 Apeiron Biologics Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Pediatric Neuroblastoma Treatment Major Product Offerings
7.3.4 Pfizer Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Pediatric Neuroblastoma Treatment Major Product Offerings
7.4.4 Bayer Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 Baxter
7.5.1 Baxter Company Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Pediatric Neuroblastoma Treatment Major Product Offerings
7.5.4 Baxter Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.5.5 Baxter Key News & Latest Developments
7.6 Cellectar Biosciences
7.6.1 Cellectar Biosciences Company Summary
7.6.2 Cellectar Biosciences Business Overview
7.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Major Product Offerings
7.6.4 Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.6.5 Cellectar Biosciences Key News & Latest Developments
7.7 MacroGenics
7.7.1 MacroGenics Company Summary
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics Pediatric Neuroblastoma Treatment Major Product Offerings
7.7.4 MacroGenics Pediatric Neuroblastoma Treatment Revenue in Global Market (2018-2023)
7.7.5 MacroGenics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pediatric Neuroblastoma Treatment Market Opportunities & Trends in Global Market
Table 2. Pediatric Neuroblastoma Treatment Market Drivers in Global Market
Table 3. Pediatric Neuroblastoma Treatment Market Restraints in Global Market
Table 4. Key Players of Pediatric Neuroblastoma Treatment in Global Market
Table 5. Top Pediatric Neuroblastoma Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pediatric Neuroblastoma Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pediatric Neuroblastoma Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pediatric Neuroblastoma Treatment Product Type
Table 9. List of Global Tier 1 Pediatric Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Neuroblastoma Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pediatric Neuroblastoma Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pediatric Neuroblastoma Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pediatric Neuroblastoma Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2024-2029
Table 30. United Therapeutics Company Summary
Table 31. United Therapeutics Pediatric Neuroblastoma Treatment Product Offerings
Table 32. United Therapeutics Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. United Therapeutics Key News & Latest Developments
Table 34. Apeiron Biologics Company Summary
Table 35. Apeiron Biologics Pediatric Neuroblastoma Treatment Product Offerings
Table 36. Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Apeiron Biologics Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Pediatric Neuroblastoma Treatment Product Offerings
Table 40. Pfizer Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Pediatric Neuroblastoma Treatment Product Offerings
Table 44. Bayer Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. Baxter Company Summary
Table 47. Baxter Pediatric Neuroblastoma Treatment Product Offerings
Table 48. Baxter Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Baxter Key News & Latest Developments
Table 50. Cellectar Biosciences Company Summary
Table 51. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product Offerings
Table 52. Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Cellectar Biosciences Key News & Latest Developments
Table 54. MacroGenics Company Summary
Table 55. MacroGenics Pediatric Neuroblastoma Treatment Product Offerings
Table 56. MacroGenics Pediatric Neuroblastoma Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. MacroGenics Key News & Latest Developments
List of Figures
Figure 1. Pediatric Neuroblastoma Treatment Segment by Type in 2022
Figure 2. Pediatric Neuroblastoma Treatment Segment by Application in 2022
Figure 3. Global Pediatric Neuroblastoma Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pediatric Neuroblastoma Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pediatric Neuroblastoma Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2022
Figure 8. By Type - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 16. US Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 28. China Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pediatric Neuroblastoma Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pediatric Neuroblastoma Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. United Therapeutics Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Baxter Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. MacroGenics Pediatric Neuroblastoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
